BDBM50085036 4-Cyclopropylethynyl-5,6-difluoro-4-trifluoromethyl-3,4-dihydro-1H-benzo[1,2,6]thiadiazine 2,2-dioxide::CHEMBL299935
SMILES: Fc1ccc2NS(=O)(=O)NC(C#CC3CC3)(c2c1F)C(F)(F)F
InChI Key: InChIKey=XFLTZZDQDDBAMD-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase (Human immunodeficiency virus 1) | BDBM50085036 (4-Cyclopropylethynyl-5,6-difluoro-4-trifluoromethy...) | PDB MMDB UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 2.47E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
DuPont Pharmaceuticals Company Curated by ChEMBL | Assay Description The compound was evaluated for the inhibition of HIV-1 reverse transcriptase | Bioorg Med Chem Lett 10: 193-5 (2000) BindingDB Entry DOI: 10.7270/Q21G0MSH | |||||||||||
More data for this Ligand-Target Pair |